JNC Premium Royal Jelly

Country: Awstralja

Lingwa: Ingliż

Sors: Department of Health (Therapeutic Goods Administration)

Ingredjent attiv:

Royal Jelly fresh, Quantity: 1.5 g (Equivalent: Royal jelly lyophilised, Qty 500 mg; Equivalent: 10-hydroxy-2-decenoic acid, Qty 30 mg)

Disponibbli minn:

JNC Co Pty Ltd T/a Panax Pharm T/a Dr. Pro

Għamla farmaċewtika:

Capsule, hard

Kompożizzjoni:

Excipient Ingredients: purified water; colloidal anhydrous silica; Gelatin; magnesium stearate; glycerol

Rotta amministrattiva:

Oral

Indikazzjonijiet terapewtiċi:

Maintain/support collagen health ; Helps enhance/promote general health and wellbeing ; Maintain/support general health and wellbeing ; Maintain/support hair health ; Anti-inflammatory/relieve inflammation ; Helps maintain/support healthy cholesterol ; Maintain/support immune system health ; Decrease/reduce/relieve symptoms of premenstrual tension ; Soothe/relieve skin inflammation

Sommarju tal-prodott:

Visual Identification: ;

L-istatus ta 'awtorizzazzjoni:

Licence status A

Data ta 'l-awtorizzazzjoni:

2019-02-04